Form D · Other

Hyver Labs, LLC

Phoenix, AZ · CIK 0001738320

Offering snapshot reported Apr 13, 2021 · SEC filing

Reported sold: $820K
Investors reported: 12
Minimum accepted: $0
First sale: Feb 24, 2020

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$102,417 → $820,417
Reported investors7 → 12

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Apr 13, 2021	Amendment	$820,417	$718,000vs Feb 25, 2020	12	SEC filing
Feb 25, 2020	Initial	$102,417	No comparison	7	SEC filing
Apr 24, 2018	Initial	$550,000	No comparison	10	SEC filing

Offering details

Securities: Debt, Option to acquire
Exemptions: 06b
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-361276

Item 13(b) includes the exchange of six promissory notes in the aggregate principal amount of $90,416 for convertible notes of equal principal amount in this offering.

Source: Form D, filed Apr 13, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Michael Bell	Executive, Promoter
Gregory Lim	Director, Executive
Kirk Morales	Director, Executive

Issuer details

Industry: Other (See others in industry)

Address:

515 E. Grant Street, Suite 150
Phoenix, AZ, 85004